The RSPO2 anti-oncogenic role on CRC growth depends on the LGR5 presence on neoplastic cells: RSPO2 may function as a tumor suppressor by negatively regulating WNT signaling through a LGR5-dependent manner [128]. The gene discussed is RSPO2; the disease is colorectal carcinoma.